Mr. Firmenich is Co-Founder of Alatus and Managing Director of Aquilus Pte Ltd in Singapore. He has been managing various investment portfolios since 1993 and actively investing with Mr. Vogel for over two decades. Between 2004 and 2015, he served on the Board of Sentarom, the holding company of the Firmenich group, acting as its Chairman since 2009. He is a director of Firmenich International, serving on its Audit Committee and previously on its Nomination Committee as well as Governance & Compensation Committee. He is a past director of Nobel Biocare, the world’s largest implant & digital dentistry firm and a past director and manager of Finarom SPF, a diversified Luxembourg investment company. He has been appointed by the President of Stanford University to the Advisory Council of its Graduate School of Business. Mr. Firmenich has extensive experience in managing industrial businesses and a deep knowledge of corporate governance. From 1996 to 2006, he held a number of successful global executive management positions within Firmenich International, the world’s second largest flavor and fragrance producer. Between 1995 and 1996, as Executive in Residence at Sierra Ventures, he developed and implemented the early-stage investment strategies for BB Biotech, then the world’s largest biotech fund ($450m). Prior he was a fellow at the Howard Hughes Medical Institute at Stanford University and an investigator at the Center for Cancer Research at MIT.
Mr. Firmenich earned an MBA from Stanford University, a Ph.D. in Biochemistry from Stanford Medical School (under the tutelage of Dr. Paul Berg, Nobel Laureate), and a B.Sc. in Life Sciences from MIT, where he was John Asinari award winner, Scholastic All-American, and elected to Phi Beta Kappa and Sigma Xi.